A.R.T. Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-4,514
Closed -$479K 1768
2014
Q2
$479K Buy
+4,514
New +$443K 0.02% 794

A.R.T. Advisors's FURX Position: Q3 2014 in Review

A.R.T. Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 4,514 shares — an estimated $479K sold.

A.R.T. Advisors first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $479K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • A.R.T. Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • A.R.T. Advisors sold 4,514 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $479K.
  • A.R.T. Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • A.R.T. Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $479K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on A.R.T. Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.